医学
心力衰竭
糖尿病
重症监护医学
2型糖尿病
流行病学
人口
疾病
内科学
心脏病
心脏病学
内分泌学
环境卫生
作者
Shannon M. Dunlay,Michael M. Givertz,David Aguilar,Larry A. Allen,Michael Chan,Akshay S. Desai,Anita Deswal,Victoria Vaughan Dickson,Mikhail Kosiborod,Carolyn L. Lekavich,Rozalina G. McCoy,Robert J. Mentz,Ileana L. Piña
出处
期刊:Circulation
[Lippincott Williams & Wilkins]
日期:2019-06-06
卷期号:140 (7)
被引量:521
标识
DOI:10.1161/cir.0000000000000691
摘要
Type 2 diabetes mellitus is a risk factor for incident heart failure and increases the risk of morbidity and mortality in patients with established disease. Secular trends in the prevalence of diabetes mellitus and heart failure forecast a growing burden of disease and underscore the need for effective therapeutic strategies. Recent clinical trials have demonstrated the shared pathophysiology between diabetes mellitus and heart failure, the synergistic effect of managing both conditions, and the potential for diabetes mellitus therapies to modulate the risk of heart failure outcomes. This scientific statement on diabetes mellitus and heart failure summarizes the epidemiology, pathophysiology, and impact of diabetes mellitus and its control on outcomes in heart failure; reviews the approach to pharmacological therapy and lifestyle modification in patients with diabetes mellitus and heart failure; highlights the value of multidisciplinary interventions to improve clinical outcomes in this population; and outlines priorities for future research.
科研通智能强力驱动
Strongly Powered by AbleSci AI